IL2 and Hyperkeratosis: The groups treated with anti-IL-2/IL-2 complex showed marked improvement in parakeratosis, acanthosis, hyperkeratosis, and lymphocyte infiltration (P-value ≤ 0.005) as shown in Fig. 5I and K. in addition, the thickness of epidermis showed improvement as compared to control.